Ulcerative Colitis
Conditions
Interventions
nutritional guidance (intervention group)
control group
Sponsors
Saitama Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients had mild active UC (patients with a UCEIS score of 2-4 points, CAI score of 5-6 points, and a distribution of the UCEIS and CAI scores at admission indicating that the patient was not in remission) were enrolled in the study.
Exclusion criteria
Exclusion criteria: Patients undergoing colonoscopy without pretreatment; those with difficulty following nutritional guidance; those with an intestinal obstruction, fistula, history of colorectal surgery, moderate to severe active-phase UC, diverticulitis, or massive colorectal bleeding; and those with anemia or other underlying conditions except UC were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint was clinical remission at 24 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints were the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) scores, the clinical activity index (CAI) evaluated based on symptoms, and biomarkers, including the zinc levels, at 12 and 24 weeks. | — |
Countries
Japan
Contacts
Public ContactKazuya Miyaguchi
Saitama Medical University Department of Gastroenterology
Outcome results
None listed